Altimmune, Inc.
ALT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $40K | $20K | +100% |
| Operating income | −$94.5M | −$103M | +8.4% |
| Net income | −$88.1M | −$95.1M | +7.3% |
Questions
- What was Altimmune's revenue in FY2025?
- $40K in FY2025 (Fiscal year ended Dec 31, 2025), +100% vs $20K a year earlier, per its 10-K filed Mar 2026.
- Was Altimmune profitable in FY2025?
- No: net income was −$88.1M and operating income −$94.5M in FY2025.